If you’re comparing gummy vitamins to tablets or capsules, it’s tempting to boil the decision down to a simple unit cost: “What does one gummy cost?” vs. “What does one pill cost?” From a manufacturing standpoint, that’s rarely the number that decides whether a product is truly cost-effective.
The better question is more practical: what does it cost to make, package, test, store, and ship a supplement that still meets its label claim and quality standards over its full shelf life? That full-picture view is where gummies and pills separate fast-and where most cost comparisons miss the point.
The cost metric most brands overlook: “shippable potency”
In real production, you don’t just pay for ingredients and a bottle. You pay for everything required to deliver a dose that remains label-compliant and sellable after processing, warehousing, and distribution. Think of it as the economics of shippable potency: the cost of a product that survives the real world without drifting out of spec or becoming a customer service headache.
1) Gummies start with more “non-active” material
Tablets and capsules are often relatively lean formulas: active ingredients plus small amounts of excipients that help with flow, compression, and encapsulation. Gummies are different by design. They’re built on a confection-style base before you even get to the actives.
That gummy base typically includes multiple components that each bring their own sourcing, specification, and handling requirements. More components also means more variables to control-especially when you scale.
Why that matters to cost
- More raw material SKUs to qualify, receive, and manage
- More incoming review (paperwork, COA checks, lot-to-lot consistency)
- More opportunities for variability that can trigger holds or adjustments
2) Yield and scrap: gummies have more ways to quietly lose money
When someone quotes a gummy price versus a tablet price, that number usually assumes ideal output. On a manufacturing floor, cost is heavily influenced by yield: how much of the batch turns into finished goods you can confidently ship.
Common yield drains in gummy production
- Moisture targets that are too high or too low, leading to handling or texture issues
- Deposit weight variation that complicates label accuracy and uniformity
- Curing/drying time that introduces capacity limits and timing risk
- Cosmetic defects like sticking, clumping, scuffing, or deformation that reduce pack-out
- Limited rework options depending on the gummy system and quality requirements
Why tablets and capsules are often more predictable
Tableting and encapsulation aren’t “automatic” and they do require tight control-but the processes are generally faster and less dependent on variables like cure time and ambient humidity. In many cases, that means fewer surprises between batch completion and final pack-out.
3) Stability planning creates an “overage tax”-often higher for gummies
To keep a supplement compliant through its shelf life, manufacturers may formulate with overages, meaning they add more than the label claim at the time of production to account for expected losses over time. That isn’t a gimmick; it’s a common stability strategy used to support label accuracy as the product ages.
Gummies frequently demand more stability planning because the process and the finished format can be tougher on actives. Without getting into any specific ingredient claims, the general stressors are well known: heat exposure, moisture, and the product’s acid/sweetener system, along with oxygen exposure depending on the package.
How overages change the real cost comparison
A gummy can look cost-competitive until you compare these two numbers side by side:
- Cost per labeled amount (what the label says)
- Cost per amount actually dosed into the batch (after stability-driven overage)
That gap is often where gummy economics shift.
4) Packaging and freight: gummies often cost more to protect and ship
Packaging isn’t just branding-it’s part of your stability system. Gummies are especially sensitive to changes in moisture and temperature, which can affect texture and pack-out quality. That pushes packaging decisions from “nice to have” into “must be engineered.”
Where gummy packaging costs can climb
- More robust seals and liners to reduce moisture exchange
- Desiccant strategies that must be tuned (too aggressive can overdry; too weak can allow clumping)
- Larger bottles and higher total weight per serving, which increases freight
A cleaner way to compare
Instead of looking at freight per bottle, compare freight per 1,000 servings. Gummies often ship more mass and more packaging per serving than tablets or capsules, and those costs show up quickly at scale-especially in e-commerce.
5) QA/QC workload: gummies can behave like a “supplement + food” hybrid
Both gummies and pills should be produced under supplement cGMP with strong quality systems. But gummies tend to require more in-process attention because product quality is tied to factors like moisture management, environmental control, and cosmetic outcomes.
What that looks like in practice
- More in-process checks related to piece quality and consistency
- Greater sensitivity to humidity and handling conditions
- More investigations when appearance or pack-out deviates from specification
Even if the final testing panel looks similar on paper, gummy production can drive higher operational QA time-which is a real cost.
6) Throughput and capacity: the hour-by-hour economics often favor pills
Here’s a manufacturing reality that rarely makes it into marketing conversations: time is a cost center. Tablet presses and capsule fillers can produce high volumes efficiently. Gummies typically involve cooking, depositing, and curing/drying steps that take time and physical space, and curing capacity can become a bottleneck.
When you compare formats, it’s worth asking not just “What’s the per-bottle price?” but “How many finished, packaged servings can we reliably produce per hour?” That throughput difference often explains why pills win on baseline COGS.
So which format is cheaper?
In many cases, tablets and capsules come out ahead on pure manufacturing economics because they tend to offer better throughput, lower freight per serving, and fewer pack-out complications.
Gummies can still be a smart business decision when the formulation is designed realistically for the format, packaging is engineered early, and the brand values consumer preference enough to justify the added complexity.
How to run an apples-to-apples comparison with KorNutra
If you want a cost comparison that reflects real manufacturing conditions (not best-case assumptions), ask for these four items for both formats:
- Fully loaded COGS per 1,000 servings (not per bottle)
- Yield and scrap assumptions-and what variables drive them
- Overage assumptions tied to shelf-life goals and packaging choice
- Landed cost sensitivity to temperature and humidity during storage and shipping
Those questions tend to surface the true cost drivers quickly and help you choose the format based on delivered value-not just a unit price on a spreadsheet.